HIGHLIGHTS
- who: Congbin Pan and colleagues from the Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Medical College, University of Science and Technology, China have published the research work: Actin-Binding Proteins in Cardiac Hypertrophy, in the Journal: Cells 2022, 11, x. of /2022/
- what: The authors briefly review the recent research progress on the various ABPs associated with cardiac hypertrophy, which has provided new strategies and targets for treating and reversing pathological hypertrophy.
SUMMARY
Cardiac hypertrophy is the early pathological structural feature of heart failure and Cardiac hypertrophy is the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.